Skip to content

Rebalancing Heart Failure

Treat a root cause of heart failure with a frontline therapy that leverages Splanchnic Ablation for Volume Management (SAVM).

Introducing the Satera™ Ablation System, a novel catheter that selectively ablates a nerve pathway and aims to restore volume balance, increase cardiac functional capacity and improve symptoms for heart failure patients with preserved ejection fraction (HFpEF).

Targeted Ablation
Minimally Invasive, implant-free procedureMinimally Invasive, implant-free procedure
Designed to reverse heart congestionDesigned to reverse heart congestion
Safe, Innovative solutionSafe, Innovative solution


The Satera Ablation System is an investigational device and is not currently approved for clinical use in any geography.

CAUTION – Investigational Device. Limited by Federal (or United States) law to Investigational Use.

©2021 Axon Therapies Inc. All rights reserved. Satera is a trademark of Axon Therapies, Inc.